INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,038,421 | -16.7% | 635,185 | -30.4% | 0.29% | -11.4% |
| Q2 2023 | $19,245,373 | +23.8% | 912,103 | 0.0% | 0.32% | +14.0% |
| Q1 2023 | $15,551,356 | +11.4% | 912,103 | +30.6% | 0.28% | +3.6% |
| Q4 2022 | $13,954,292 | +424.4% | 698,413 | +232.6% | 0.28% | +84.6% |
| Q1 2016 | $2,661,000 | -30.2% | 210,000 | 0.0% | 0.15% | -22.0% |
| Q4 2015 | $3,812,000 | +42.0% | 210,000 | +45.2% | 0.19% | +22.4% |
| Q3 2015 | $2,685,000 | +24.1% | 144,600 | +63.2% | 0.16% | +33.3% |
| Q2 2015 | $2,164,000 | +17.4% | 88,600 | 0.0% | 0.12% | -15.8% |
| Q1 2015 | $1,843,000 | +34.4% | 88,600 | 0.0% | 0.14% | -7.3% |
| Q4 2014 | $1,371,000 | +18.6% | 88,600 | 0.0% | 0.15% | -6.8% |
| Q3 2014 | $1,156,000 | -34.7% | 88,600 | 0.0% | 0.16% | -33.2% |
| Q2 2014 | $1,770,000 | +29.1% | 88,600 | +23.1% | 0.24% | +13.1% |
| Q1 2014 | $1,371,000 | +144.8% | 72,000 | +118.8% | 0.21% | +23.1% |
| Q4 2013 | $560,000 | – | 32,900 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |